跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CABAZITAXEL ACCORD cabazitaxel 60 mg/3 mL concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
CABAZITAXEL ACCORD cabazitaxel 60 mg/3 mL concentrated injection vial
Approved
STANDARD
CABAZITAXEL ACCORD cabazitaxel 60 mg/3 mL concentrated injection vial
Accord Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b88796a870241bc5
Company
Accord Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
b88796a870241bc5
Product Name
CABAZITAXEL ACCORD cabazitaxel 60 mg/3 mL concentrated injection vial
Artg Id
340843
Artg Name
CABAZITAXEL ACCORD cabazitaxel 60 mg/3 mL concentrated injection vial
Sponsor
Accord Healthcare Pty Ltd
Company Detail Path
/organization/accord-healthcare-pty-ltd
Artg Date
2021-08-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4d01fb67d03f10a10014d1c4183e3083.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/386fb4fada6cc3e2fdce155d18de8efa.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b88796a870241bc5
Type
Standard
Back to TGA Approvals